Related references
Note: Only part of the references are listed.Metabolic syndrome and peripheral neuropathy
Mohamed Kazamel et al.
MUSCLE & NERVE (2021)
Improvements in Diabetic Neuropathy and Nephropathy After Bariatric Surgery: a Prospective Cohort Study
Safwaan Adam et al.
OBESITY SURGERY (2021)
A systematic review and meta-analysis of the serum lipid profile in prediction of diabetic neuropathy
Zixin Cai et al.
SCIENTIFIC REPORTS (2021)
Bariatric surgery leads to an improvement in small nerve fibre damage in subjects with obesity
Shazli Azmi et al.
INTERNATIONAL JOURNAL OF OBESITY (2021)
Lipids and peripheral neuropathy
Zohaib Iqbal et al.
CURRENT OPINION IN LIPIDOLOGY (2021)
Diagnosis of Neuropathy and Risk Factors for Corneal Nerve Loss in Type 1 and Type 2 Diabetes: A Corneal Confocal Microscopy Study
Maryam Ferdousi et al.
DIABETES CARE (2021)
Statin use and peripheral nerve function-A prospective follow-up study
Toke de Koning Svendsen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2020)
The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange
Kara R. Mizokami-Stout et al.
DIABETES CARE (2020)
Metabolic Factors, Lifestyle Habits, and Possible Polyneuropathy in Early Type 2 Diabetes: A Nationwide Study of 5,249 Patients in the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Cohort
Diana H. Christensen et al.
DIABETES CARE (2020)
Quantitative evaluation of statin effectiveness versus intolerance and strategies for management of intolerance
Handrean Soran et al.
ATHEROSCLEROSIS (2020)
Statin Therapy and Risk of Polyneuropathy in Type 2 Diabetes: A Danish Cohort Study
Frederik P. Kristensen et al.
DIABETES CARE (2020)
Corneal Nerve and Brain Imaging in Mild Cognitive Impairment and Dementia
Eiman Al-Janahi et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
PCSK9 monoclonal antibody treatment promotes small fibre regeneration in heterozygous familial hypercholesterolemia
H. Soran et al.
ATHEROSCLEROSIS (2020)
Oxidized LDL Causes Endothelial Apoptosis by Inhibiting Mitochondrial Fusion and Mitochondria Autophagy
Jia Zheng et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Statins-related peripheral neuropathy among diabetic patients
Mohamed A. Hammad et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Statins and Neuropathic Pain: A Narrative Review
Joseph V. Pergolizzi et al.
PAIN AND THERAPY (2020)
Association of corneal nerve fiber measures with cognitive function in dementia
Georgios Ponirakis et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
Connie B. Newman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Statin Toxicity Mechanistic Insights and Clinical Implications
Natalie C. Ward et al.
CIRCULATION RESEARCH (2019)
Prescribing Statins to Reduce Cardiovascular Disease: 10 Common Misconceptions
David S. Schade et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Acquired low cholesterol: diagnosis and relevance to safety of low LDL therapeutic targets
Handrean Soran et al.
CURRENT OPINION IN LIPIDOLOGY (2018)
Explanations for less small fibre neuropathy in South Asian versus European subjects with type 2 diabetes in the UK
Hassan Fadavi et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)
Characteristics of patients prescribed Evolocumab in Europe. Does clinical use match clinical guidelines?
K. Ray et al.
EUROPEAN HEART JOURNAL (2018)
A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial
Handrean Soran et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms
Bob G. Schultz et al.
TRANSLATIONAL NEURODEGENERATION (2018)
Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk
Handrean Soran et al.
ATHEROSCLEROSIS (2018)
Risk Factors for the Presence and Progression of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: ADDITION-Denmark
Signe T. Andersen et al.
DIABETES CARE (2018)
Corneal confocal microscopy as a tool for detecting diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes: ADDITION-Denmark
Signe T. Andersen et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2018)
Safety and efficacy of statin therapy
Bhavin B. Adhyaru et al.
NATURE REVIEWS CARDIOLOGY (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
Francois Mach et al.
EUROPEAN HEART JOURNAL (2018)
Hyperlipidemia-induced apoptosis of hippocampal neurons in apoE(-/-) mice may be associated with increased PCSK9 expression
Xue-Shan Zhao et al.
MOLECULAR MEDICINE REPORTS (2017)
Are recent statin recommendations to employ fixed doses and abandon targets effective for treatment of hypercholesterolaemia? Investigation based on number needed to treat
Handrean Soran et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis
Alessandro Squizzato et al.
INTERNAL AND EMERGENCY MEDICINE (2017)
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
Ajay Gupta et al.
LANCET (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Calorically restricted diets decrease PCSK9 in overweight adolescents
A. E. Levenson et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2017)
Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women
Amy E. Levenson et al.
PEDIATRIC DIABETES (2017)
Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy?
M. C. Perez-Matos et al.
JOURNAL OF DIABETES RESEARCH (2017)
Statins: pros and cons
Iago Pinal-Fernandez et al.
MEDICINA CLINICA (2017)
Statins and polyneuropathy revisited: case-control study in Denmark, 1999-2013
Toke de Koning Svendsen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Evidence for more intensive cholesterol lowering
Handrean Soran et al.
CURRENT OPINION IN LIPIDOLOGY (2017)
PCSK9 Is Increased in Youth With Type 1 Diabetes
Amy E. Levenson et al.
DIABETES CARE (2017)
Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapyA cognitive study of patients enrolled in the FOURIER trial
Robert P. Giugliano et al.
CLINICAL CARDIOLOGY (2017)
The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis
Michael J. Lipinski et al.
EUROPEAN HEART JOURNAL (2016)
Nerve growth factor (NGF) and pro-NGF increase low-density lipoprotein (LDL) receptors in neuronal cells partly by different mechanisms: role of LDL in neurite outgrowth
Hai Thi Do et al.
JOURNAL OF NEUROCHEMISTRY (2016)
NEUROPATHY ASSOCIATED WITH HYPERTRIGLYCERIDEMIA IN PATIENTS WITH METABOLIC SYNDROME
H. H. Beyca et al.
ACTA ENDOCRINOLOGICA-BUCHAREST (2016)
Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey
G. Kees Hovingh et al.
ATHEROSCLEROSIS (2016)
Stress-induced upregulation of VLDL receptor alters Wnt-signaling in neurons
Kai Kysenius et al.
EXPERIMENTAL CELL RESEARCH (2016)
The nocebo effect in the context of statin intolerance
Jonathan A. Tobert et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins et al.
LANCET (2016)
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition A New Therapeutic Mechanism for Reducing Cardiovascular Disease Risk
Nathalie Bergeron et al.
CIRCULATION (2015)
Corneal Confocal Microscopy Identifies Small-Fiber Neuropathy in Subjects With Impaired Glucose Tolerance Who Develop Type 2 Diabetes
Shazli Azmi et al.
DIABETES CARE (2015)
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
Erik S. Stroes et al.
EUROPEAN HEART JOURNAL (2015)
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Daniel I. Swerdlow et al.
LANCET (2015)
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Jennifer G. Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Neuropsychiatric Adverse Events Associated with Statins: Epidemiology, Pathophysiology, Prevention and Management
Marco Tuccori et al.
CNS DRUGS (2014)
Corneal Confocal Microscopy Detects Neuropathy in Subjects With Impaired Glucose Tolerance
Omar Asghar et al.
DIABETES CARE (2014)
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System
Amelia J. McFarland et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
An assessment by the Statin Diabetes Safety Task Force: 2014 update
Kevin C. Maki et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study
Sune F. Nielsen et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Higher levels of small dense low-density lipoprotein (LDL) are associated with cardiac autonomic neuropathy in patients with Type 2 diabetes
E. -H. Jang et al.
DIABETIC MEDICINE (2013)
Relaxation of porcine retinal arterioles exposed to hypercholesterolemia in vivo is modified by hepatic LDL-receptor deficiency and diabetes mellitus
Toke Bek et al.
EXPERIMENTAL EYE RESEARCH (2013)
Obesity and hyperlipidemia are risk factors for early diabetic neuropathy
A. Gordon Smith et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2013)
Statins in the prevention of dementia and Alzheimer's disease: A meta-analysis of observational studies and an assessment of confounding
William B. Wong et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Association of statin use with peripheral neuropathy in the US population 40 years of age or older
Edward F. Tierney et al.
JOURNAL OF DIABETES (2013)
Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users
Jerome D. Cohen et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Are statins diabetogenic?
Uchechukwu K. Sampson et al.
CURRENT OPINION IN CARDIOLOGY (2011)
Statins: Multiple neuroprotective mechanisms in neurodegenerative diseases
Qing Wang et al.
EXPERIMENTAL NEUROLOGY (2011)
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Diabetic neuropathy: cellular mechanisms as therapeutic targets
Andrea M. Vincent et al.
NATURE REVIEWS NEUROLOGY (2011)
Short-term metabolic change is associated with improvement in measures of diabetic neuropathy: a 1-year placebo cohort analysis
B. A. Perkins et al.
DIABETIC MEDICINE (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy
Timothy D. Wiggin et al.
DIABETES (2009)
Hyperlipidemia: a new therapeutic target for diabetic neuropathy
Andrea M. Vincent et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2009)
Statin Adverse Effects A Review of the Literature and Evidence for a Mitochondrial Mechanism
Beatrice A. Golomb et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2008)
Neuroprotection by pravastatin in acute ischemic stroke in rats
Christian Berger et al.
BRAIN RESEARCH REVIEWS (2008)
Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study
T. M. E. Davis et al.
DIABETOLOGIA (2008)
Misperception among physicians and patients regarding the risks and benefits of statin treatment: the potential role of direct-to-consumer advertising
Rachel H. Kon et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2008)
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
LANCET (2008)
Hypercholesterolaemia and its management
Deepak Bhatnagar et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
High-fat diet-induced neuropathy of pre-diabetes and obesity - Effects of healthy diet and aldose reductase inhibition
Irina G. Obrosova et al.
DIABETES (2007)
Statin-associated peripheral neuropathy: Review of the literature
PH Chong et al.
PHARMACOTHERAPY (2004)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
HM Colhoun et al.
LANCET (2004)
Lipid lowering drugs prescription and the risk of peripheral neuropathy:: an exploratory case-control study using automated databases
G Corrao et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2004)
Statin-associated memory loss: Analysis of 60 case reports and review of the literature
LR Wagstaff et al.
PHARMACOTHERAPY (2003)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)
Microvascular complications of impaired glucose tolerance
JR Singleton et al.
DIABETES (2003)
Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells
H Runz et al.
JOURNAL OF NEUROSCIENCE (2002)
Statins: mechanism of action and effects
C Stancu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2001)
The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes
B Isomaa et al.
DIABETOLOGIA (2001)
Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?
D Gaist et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin
RA Stewart et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
